Cargando…
Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
Carmustine wafers (CW; Gliadel(®) wafers) are approved to treat newly-diagnosed high-grade glioma (HGG) and recurrent glioblastoma. Widespread use has been limited for several reasons, including concern that their use may preclude enrollment in subsequent clinical trials due to uncertainty about con...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368843/ https://www.ncbi.nlm.nih.gov/pubmed/25630625 http://dx.doi.org/10.1007/s11060-015-1724-2 |